Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Doximity (DOCS)

Doximity co-founder Nathan Gross steps down as Chief Strategy Officer to become advisor

Neutral Impact 3 of 5 leadership Written later

Doximity said co-founder Dr. Nathan Gross will step down as Chief Strategy Officer effective June 16, 2025, and become an advisor under an Independent Contractor Agreement dated June 13, 2025. The filing says he will receive no cash compensation for advisory services, and his existing equity awards will continue to vest through September 2025.

Key points

  • Dr. Nathan Gross notified the company on June 10, 2025 of his transition; the change takes effect June 16, 2025.
  • Advisor Agreement is dated June 13, 2025 and runs until terminated under its terms; no cash compensation will be paid.
  • RSU and option awards granted to Dr. Gross will continue to vest through September 2025.
  • The company expects to file the Advisor Agreement as an exhibit to its Form 10-Q for the quarter ending June 30, 2025.

The filing

CompanyDoximity (DOCS)
Form8-K, current report
Filed with the SECJun 13, 2025, 4:02 PM ET
Accession number0001516513-25-000065

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 12:59 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 13, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.